E
Sell
3/4/2025Downgrade
Cytek Biosciences, Inc. (CTKB) was downgraded to E+ from D- on 3/4/2025 due to a decline in the growth index and volatility index. Operating cash flow declined 84.9% from $13.22M to $2M.
D
Sell
2/6/2025Upgraded
Cytek Biosciences, Inc. (CTKB) was upgraded to D- from E+ on 2/6/2025 due to a significant increase in the growth index, total return index and volatility index. Operating cash flow increased 113.1% from $6.2M to $13.22M, earnings per share increased from -$0.08 to $0.0072, and EBIT increased 50.18% from -$8.53M to -$4.25M.
E
Sell
5/14/2024Downgrade
Cytek Biosciences, Inc. (CTKB) was downgraded to E+ from D on 5/14/2024 due to a substantial decline in the efficiency index, total return index and volatility index. Net income declined 212.1% from $5.5M to -$6.17M, and total capital declined 0.05% from $407.2M to $407.01M.
D
Sell
3/14/2024Upgraded
Cytek Biosciences, Inc. (CTKB) was upgraded to D from E+ on 3/14/2024 due to a substantial increase in the efficiency index, total return index and volatility index. Net income increased 185.24% from -$6.46M to $5.5M.
E
Sell
8/9/2023Downgrade
Cytek Biosciences, Inc. (CTKB) was downgraded to E+ from D on 8/9/2023 due to a significant decline in the efficiency index, total return index and growth index. Operating cash flow declined 199.72% from $2.86M to -$2.85M, and total capital declined 0.08% from $440.72M to $440.39M.
D
Sell
12/10/2021Downgrade
Cytek Biosciences, Inc. (CTKB) was downgraded to D from D+ on 12/10/2021 due to a large decline in the volatility index and total return index.
D
Sell
11/18/2021Downgrade
Cytek Biosciences, Inc. (CTKB) was downgraded to D+ from C- on 11/18/2021 due to a large decline in the volatility index, valuation index and efficiency index. Net income declined 46.82% from $2.67M to $1.42M.
C
Hold
11/3/2021Upgraded
Cytek Biosciences, Inc. (CTKB) was upgraded to C- from D+ on 11/3/2021 due to a significant increase in the total return index.
D
Sell
10/15/2021None
Cytek Biosciences, Inc. (CTKB) was downgraded to D+ from U on 10/15/2021.
